[Gonadotrophin-releasing hormone antagonists: application in ovary-stimulating and sex-steroid dependent disorders]
- PMID: 10703589
[Gonadotrophin-releasing hormone antagonists: application in ovary-stimulating and sex-steroid dependent disorders]
Abstract
The hypothalamic gonadotrophin-releasing hormone (GnRH) stimulates synthesis and secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH) by the gonadotrophic cells of the pituitary. The mechanisms of action of GnRH antagonists and of agonists is completely different. Due tot competitive blockage of GnRH receptors by antagonist administration, LH (and to a lesser extent FSH) levels drop rapidly. Moreover pituitary function normalizes immediately following cessation of medication. The direct and rapid action of GnRH antagonists, the dose dependent suppression of LH and FSH and the rapid restoration of hypophyseal function after cessation of the use of antagonists may shorten and simplify in-vitro fertilization, with less chance of side effects or complications. Further studies are required to decide whether antagonists can usefully be applied for other gynecological indications such as the polycystic ovary syndrome. The possibilities of profitable long term treatment will increase considerably if it proves possible to develop a sustained action formulation.
Similar articles
-
Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.Hum Reprod. 2015 May;30(5):1188-95. doi: 10.1093/humrep/dev038. Epub 2015 Mar 3. Hum Reprod. 2015. PMID: 25740882 Clinical Trial.
-
Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists.J Clin Endocrinol Metab. 1990 Feb;70(2):328-35. doi: 10.1210/jcem-70-2-328. J Clin Endocrinol Metab. 1990. PMID: 2105329
-
The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist.Fertil Steril. 2010 Mar 15;93(5):1668-75. doi: 10.1016/j.fertnstert.2008.12.047. Epub 2009 Feb 6. Fertil Steril. 2010. PMID: 19200975 Free PMC article.
-
The role of gonadotropin-releasing hormone antagonists in in vitro fertilization.Semin Reprod Med. 2001 Sep;19(3):213-20. doi: 10.1055/s-2001-18040. Semin Reprod Med. 2001. PMID: 11679902 Review.
-
Developments in drugs for ovarian stimulation.Best Pract Res Clin Obstet Gynaecol. 2003 Apr;17(2):231-47. doi: 10.1016/s1521-6934(02)00168-2. Best Pract Res Clin Obstet Gynaecol. 2003. PMID: 12758097 Review.